ASLAN Pharmaceuticals Ltd (ASLN)
0.2903
-0.02
(-4.98%)
USD |
NASDAQ |
Jun 26, 16:00
0.2903
0.00 (0.00%)
After-Hours: 20:00
ASLAN Pharmaceuticals Shares Outstanding: 22.63M for May 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 31, 2024 | 22.63M |
April 01, 2024 | 22.63M |
March 31, 2024 | 22.63M |
March 14, 2024 | 22.63M |
December 31, 2023 | 17.60M |
September 30, 2023 | 17.27M |
June 30, 2023 | 16.67M |
February 28, 2023 | 16.35M |
December 31, 2022 | 13.95M |
June 30, 2022 | 13.95M |
January 24, 2022 | 13.95M |
December 31, 2021 | 13.95M |
June 30, 2021 | 13.92M |
March 31, 2021 | 13.90M |
March 15, 2021 | 13.40M |
March 05, 2021 | 13.39M |
March 02, 2021 | 10.39M |
February 25, 2021 | 9.412M |
December 31, 2020 | 8.387M |
September 30, 2020 | 7.598M |
June 30, 2020 | 7.598M |
Date | Value |
---|---|
February 29, 2020 | 7.598M |
December 31, 2019 | 7.598M |
December 06, 2019 | 7.598M |
November 08, 2019 | 6.41M |
October 31, 2019 | 6.41M |
September 30, 2019 | 6.41M |
June 30, 2019 | 6.41M |
June 17, 2019 | 6.41M |
March 31, 2019 | 6.41M |
January 01, 2019 | 6.41M |
December 31, 2018 | 6.41M |
September 30, 2018 | 6.41M |
June 30, 2018 | 6.405M |
May 08, 2018 | 5.205M |
March 31, 2018 | 5.205M |
December 31, 2017 | 5.205M |
September 30, 2017 | 5.205M |
August 18, 2017 | 5.205M |
June 30, 2017 | 5.205M |
June 01, 2017 | 5.205M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
6.41M
Minimum
Jun 30 2019
22.63M
Maximum
Mar 14 2024
12.88M
Average
13.65M
Median
Shares Outstanding Benchmarks
Dr Reddy's Laboratories Ltd | 166.54M |
Concord Medical Services Holdings Ltd | 43.42M |
Zai Lab Ltd | 98.72M |
WAVE Life Sciences Ltd | 122.46M |
CytoMed Therapeutics Ltd | 11.54M |